Gujarat Medical Education & Research Society

Anti Ragging Toll Free Helpline No : 1800-180-5522

Dr. Mitul R Parmar  (Pharmacology)

Name : Dr. Mitul R Parmar
Mobile Number :
Email ID : mitulparmar18@gmail.com
Blood Group A+ve
Designation : Tutor
Department : Pharmacology
Qualification : MBBS
UG : Kesar Sal Medical college, Ahmedabad
PG :
Joining Date : 20/12/2011
Total Teaching Expereince 10 years
Extra Details 1 :
Extra Details 2 :
Publication Details :

 

1. Kalariya H, Panchasara AK, ParmarM, Vora MB. Drug utilisation pattern of anti-hypertensive drugsin a tertiary care hospital:  AProspective, Cross sectional study. International Journal of PharmacologyResearch 2018, Vol 8 (2) Page: 72-76.

 

2.       Pandya AS, Panchal PJ, Kataria BC, Parmar MR.Evaluation of knowledge regarding good clinical practice among faculties at atertiary care teaching hospital. Int J Clin Trials 2015;2:xxx-xx.

 

3.     Kataria BC, Pandya AS, Panchasara AK, Panchal PJ,Parmar MR. Drug lag for antineoplastic and immunomodulating agent approvals inIndia compared with the US and EU approvals. Int J Basic Clin Pharmacol2016;5:335-40.

 

  1. Panchal PJ, Pandya AS, Parmar MR. Knowledge, attitude and practice of self medication among under graduate M.B.B.S. students at tertiary care teaching hospital. Int J Health Sci Res. 2015; 5(7):192-197.

 

  1. Kataria BC, Panchasara AK, Pandya AS, Panchal PJ, Parmar MR. Contemplation on new drug approvals by U.S. FDA, 2011-2015. Int J Basic Clin Pharmacol 2016;5:55-9.

 

  1. Kataria BC, Panchal PJ, Panchasara AK, Pandya AS, Parmar MR. Comparison of new drug approval by regulatory agencies of US, EU and India. Int J Basic Clin Pharmacol 2016;5:112-5.

Conference Workshop Details :
Achievement Details :
Teaching Experience :
Qualification :
Qualification College University Year RegistrationNo NameOfMedicalCouncil
MBBS Kesar Sal Medical College Ahmedabad Gujarat University 2010 G-46058 GUJARAT MEDICAL COUNCIL